Business
Why the Mesoblast share price jumped higher this morning – Motley Fool Australia
Today the Mesoblast share price jumped higher after the company announced a positive recommendation regarding its COVID-19 treatment trials.
This morning, the Mesoblast limited(ASX: MSB) share price jumped 3.14% to $5.25 after the company received a positive recommendation from the Data Safety Monitoring Board (DSMB) to continue its phase 3 trial of remestemcel-L in patients with acute COVID-19. The positive news, however, was not sufficient to sustain the Mesoblast share price amid wider share market falls with the company now trading at $5.04 at the time of writing.
What moved the Mesoblast share price?
The Mesoblast share pric…
-
Noosa News18 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business23 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General24 hours agoRush to buy homes before rate cuts send prices soaring
-
Business21 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025